AKYNZEO IV conc perf 235mg/0.25mg flac 20 ml
7680682900015
CH-68290
A04AA55
01.09.0.
Reimbursement limitations:
AKYNZEO.02
Associé à la dexaméthasone chez l’adulte pour:
- la prévention des nausées et vomissements aigus …
1 / 3
google
Details
- Product number
- 6829001
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- fosnetupitantum 235 mg ut fosnetupitantum chloridum hydrochloridum corresp. netupitantum 197.5 mg, palonosetronum 0.25 mg ut palonosetroni hydrochloridum, dinatrii edetas, mannitolum, natrii hydroxidum q.s. ad pH, acidum hydrochloridum q.s. ad pH, aqua ad iniectabile q.s. ad solutionem pro 20 ml corresp. natrium 24.4 mg.
Articles (1)
Akynzeo IV 235 mg / 0.25 mg, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
235.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
197.5 MG | Substance | WIZUS |
|
(N/A)
|
0.25 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
24.4 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 100.95
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/06/2024
Authorization holder
Medius AG
4132 Muttenz
Authorization information
- Swissmedic authorization number
- 68290
- Drug name
- Akynzeo IV, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- A04AA55
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 01/09/2022
- Authorization expiration date
- 31/08/2027
- IT number
- 01.09.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- AKYNZEO IV conc perf 235mg/0.25mg flac 20 ml
- Description (DE)
- AKYNZEO IV Inf Konz 235mg/0.25mg Durchstf 20 ml
- Market launch
- 01/09/2022
- Narcotic (BTM)
- No